Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden flag Sweden · Delayed Price · Currency is SEK
13.72
+0.02 (0.15%)
Aug 13, 2026, 5:29 PM CET

Xspray Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6501,3131,5391,2501,2811,314
Market Cap Growth
-65.90%-14.72%23.14%-2.42%-2.48%-63.83%
Enterprise Value
6171,3071,4591,1211,1631,045
Last Close Price
13.7231.4541.4540.0056.4863.52

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-3.762.022.6214.5314.53
PS Ratio
263.43204.10734.4439.35587.662002.49
PB Ratio
1.022.172.471.802.302.22
P/TBV Ratio
5.1213.089.534.146.984.14

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
250.20203.27696.2735.28533.511592.97

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.220.240.200.050.000.00
Net Debt / Equity Ratio
-0.05-0.01-0.13-0.19-0.21-0.45
Net Debt / EBITDA Ratio
0.240.040.290.750.963.02
Net Debt / FCF Ratio
0.220.030.350.630.885.08
Asset Turnover
0.020.010.000.050.000.00
Quick Ratio
1.167.101.424.274.259.16
Current Ratio
1.398.441.615.464.589.41
Return on Equity (ROE)
-25.70%-27.96%-43.42%-28.77%-22.94%-16.47%
Return on Assets (ROA)
-17.56%-20.06%-36.78%-26.91%-22.03%-15.95%
Return on Invested Capital (ROIC)
-23.11%-27.49%-51.89%-36.28%-34.97%-33.49%
Return on Capital Employed (ROCE)
-19.76%-22.45%-41.73%-28.35%-23.15%-16.62%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-17.03%-16.04%-24.60%-26.21%-9.53%-8.81%
Total Shareholder Return
-17.03%-16.04%-24.60%-26.21%-9.53%-8.81%